Inmed Pharmaceuticals Inc. · NASDAQ:INM
Ikarian Capital, LLC's stake in Inmed Pharmaceuticals Inc. fell to 4.20% (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ikarian Capital, LLC's stake in Inmed Pharmaceuticals Inc. fell to 4.20%, 137,634 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 4.20%
- Shares
- 137,634
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 4.20% | 137,634 |
| Neil Shahrestani | 4.20% | 137,634 |
Source
Related
- Inmed Pharmaceuticals Inc.
- Ikarian Capital, LLC
- Inmed Pharmaceuticals Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Oct 20, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 8, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Oct 7, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 5, 2026